Have a feature idea you'd love to see implemented?
Let us know!
STAA Staar Surgical Co
Price (delayed)
$24.82
Market cap
$1.22B
P/E Ratio
56.41
Dividend/share
N/A
EPS
$0.44
Enterprise value
$1.1B
STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are
Highlights
STAA's P/E is 70% below its 5-year quarterly average of 186.3 and 46% below its last 4 quarters average of 103.8
Staar Surgical's net income has increased by 31% from the previous quarter and by 7% YoY
STAA's quick ratio is up by 3.2% QoQ but it is down by 3% YoY
Staar Surgical's debt has increased by 11% YoY and by 10% from the previous quarter
Key stats
What are the main financial stats of STAA
Market
Valuations
Earnings
Shares outstanding
49.28M
Market cap
$1.22B
Enterprise value
$1.1B
Price to earnings (P/E)
56.41
Price to book (P/B)
2.85
Price to sales (P/S)
3.58
EV/EBIT
39.2
EV/EBITDA
32.55
EV/Sales
3.22
Revenue
$341.22M
Gross profit
$268.66M
Net income
$21.78M
EBIT
$28.04M
EBITDA
$33.76M
Free cash flow
$26.3M
Per share
Balance sheet
Liquidity
EPS
$0.44
EPS diluted
$0.44
Free cash flow per share
$0.53
Book value per share
$8.7
Revenue per share
$6.94
TBVPS
$10.89
Total assets
$537.59M
Total liabilities
$109.47M
Debt
$40M
Equity
$428.12M
Working capital
$330.77M
Debt to equity
0.09
Current ratio
5.99
Quick ratio
5.13
Net debt/EBITDA
-3.67
Margins
Efficiency
Dividend
EBITDA margin
9.9%
Gross margin
78.7%
Net margin
6.4%
Operating margin
7.5%
Return on assets
4.3%
Return on equity
5.4%
Return on invested capital
9.8%
Return on capital employed
5.9%
Return on sales
8.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STAA stock price
How has the Staar Surgical stock price performed over time
Intraday
-0.64%
1 week
-0.16%
1 month
-5.7%
1 year
-19.88%
YTD
-20.47%
QTD
-33.19%
Financial performance
How have Staar Surgical's revenue and profit performed over time
Revenue
$341.22M
Gross profit
$268.66M
Operating income
$25.7M
Net income
$21.78M
Gross margin
78.7%
Net margin
6.4%
STAA's operating income is up by 38% year-on-year but it is down by 2.3% since the previous quarter
Staar Surgical's net income has increased by 31% from the previous quarter and by 7% YoY
Staar Surgical's net margin has increased by 28% from the previous quarter but it has decreased by 3% YoY
Staar Surgical's operating margin has increased by 25% YoY but it has decreased by 5% from the previous quarter
Growth
What is Staar Surgical's growth rate over time
Valuation
What is Staar Surgical stock price valuation
P/E
56.41
P/B
2.85
P/S
3.58
EV/EBIT
39.2
EV/EBITDA
32.55
EV/Sales
3.22
STAA's P/E is 70% below its 5-year quarterly average of 186.3 and 46% below its last 4 quarters average of 103.8
Staar Surgical's EPS has increased by 29% QoQ and by 2.3% YoY
STAA's price to book (P/B) is 76% lower than its 5-year quarterly average of 12.1 and 39% lower than its last 4 quarters average of 4.7
Staar Surgical's equity has increased by 13% YoY and by 4.6% QoQ
The stock's price to sales (P/S) is 74% less than its 5-year quarterly average of 14.0 and 37% less than its last 4 quarters average of 5.7
The revenue has grown by 10% YoY and by 2.5% from the previous quarter
Efficiency
How efficient is Staar Surgical business performance
The ROIC has increased by 32% YoY and by 27% from the previous quarter
The ROE has grown by 29% from the previous quarter but it has contracted by 7% YoY
Staar Surgical's return on assets has increased by 26% QoQ but it has decreased by 9% YoY
Staar Surgical's return on sales has increased by 26% QoQ and by 8% YoY
Dividends
What is STAA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STAA.
Financial health
How did Staar Surgical financials performed over time
Staar Surgical's total liabilities has increased by 18% YoY and by 6% from the previous quarter
The total assets is up by 14% year-on-year and by 4.8% since the previous quarter
Staar Surgical's debt is 91% less than its equity
Staar Surgical's equity has increased by 13% YoY and by 4.6% QoQ
Staar Surgical's debt has increased by 11% YoY and by 10% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.